DalsnaFinance › IPOs › Annovis Bio › IPO
Annovis Bio, Inc. completed its initial public offering on NYSE on January 29, 2020, pricing at $6.00 a share.
| Ticker | ANVS |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | January 29, 2020 |
| Offering price | $6.00 |
| Shares offered | 2,000,000 |
| Total raised | $12M |
Annovis Bio, Inc. sold 2,000,000 shares at $6.00 each on NYSE. Multiplied out, that is $12 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $12 million total recorded for the deal.
Annovis Bio, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Annovis Bio, Inc.. This page is general information, not investment advice.